Reply to the Letter to the Editor “Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Reply to the Letter to the Editor “Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease” ; volume:29 ; number:1 ; year:2020 ; pages:98-98
Medical principles and practice ; 29, Heft 1 (2020), 98-98
- Creator
-
Kutlu, Orkide
Altun, Özgür
Dikker, Okan
Aktaş, Şerife
Özsoy, Neslihan
Arman, Yücel
Özgün Çil, Eylem
Özcan, Mustafa
Aydın Yoldemir, Şengül
Akarsu, Murat
Toprak, İlkim Deniz
Kırna, Kerem
Kutlu, Yasin
Toprak, Zeki
Eruzun, Hasan
Tükek, Tufan
- DOI
-
10.1159/000502106
- URN
-
urn:nbn:de:101:1-2020021223123605315454
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kutlu, Orkide
- Altun, Özgür
- Dikker, Okan
- Aktaş, Şerife
- Özsoy, Neslihan
- Arman, Yücel
- Özgün Çil, Eylem
- Özcan, Mustafa
- Aydın Yoldemir, Şengül
- Akarsu, Murat
- Toprak, İlkim Deniz
- Kırna, Kerem
- Kutlu, Yasin
- Toprak, Zeki
- Eruzun, Hasan
- Tükek, Tufan
Other Objects (12)
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Reply to Letter to Editor: Congenital Disease of the Hip
Reply to “The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor”
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
To die or not to die: death signaling in nonalcoholic fatty liver disease
Excitatory amino acid antagonists and Parkinson's disease [Reply to letter to the editor]
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Reply to Letter to Editor: Congenital Disease of the Hip
Reply to “The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor”
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
To die or not to die: death signaling in nonalcoholic fatty liver disease
Excitatory amino acid antagonists and Parkinson's disease [Reply to letter to the editor]
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease
Reply to Letter to Editor: Congenital Disease of the Hip
Reply to “The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor”
Nonalcoholic fatty liver disease and cardiovascular disease risk
Non-alcoholic fatty liver disease
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
To die or not to die: death signaling in nonalcoholic fatty liver disease
Excitatory amino acid antagonists and Parkinson's disease [Reply to letter to the editor]
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease